Additionally, our results showed that HE4 mRNA and protein expression were increased in both plasma and tumor tissue of high-grade BC; therefore, patients with grade III had the highest HE4 expression level compared with grade I and II. This evidence concerns the gene WFDC2 and breast cancer.